Gehani, Neal C <br/><br/>
Significance of cannabinoid CB1 receptors in improgan antinociception.  [electronic resource] 

 -  The journal of pain  Nov 2007 
 - 850-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-5900 
<br/><br/><label>Standard No.: </label>10.1016/j.jpain.2007.05.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--administration & dosage<br/>Analysis of Variance<br/>Animals<br/>Cimetidine--administration & dosage<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Guanosine 5'-O-(3-Thiotriphosphate)--metabolism<br/>Injections, Intraventricular--methods<br/>Male<br/>Pain--drug therapy<br/>Pain Measurement--methods<br/>Pain Threshold--drug effects<br/>Piperidines--administration & dosage<br/>Pyrazoles--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reaction Time--drug effects<br/>Receptor, Cannabinoid, CB1--agonists<br/>Rimonabant<br/>Time Factors